The limitations of dominant methods-based on the detection of
anti-HCV antibodies or HCV
viremia currently used for the diagnosis of HCV
infection enhance efforts to have a rapid, simple, sensitive, and specific alternative diagnostic approach to detect
viral antigens. A highly reactive
IgG antibody was raised to HCV-NS4 recombinant
antigen. The produced antibody showed no cross-reactivity with the other HCV structural and nonstructural recombinant
antigens (C1 + 2, C3 + 4, E2/NS1, NS3, NS5). The well established ELISA technique was adapted to detect the new target HCV-NS4
antigen in serum samples. Extremely high agreement was found between the results of ELISA and qualitative detection of HCV-
RNA, using a RT-PCR test as a gold standard for the diagnosis of HCV
infection. Based on these encouraging results, a novel
enzyme immunoassay; dot-ELISA was developed for rapid (approximately 5 min) and simple qualitative detection of the target HCV
antigen in serum. The developed method detected the HCV target
antigen in 95% of serum samples from HCV infected individuals, with a specificity of 97% using sera of noninfected individuals in comparison with PCR test. The
antigen detection method showed high predictive values of positive (99%) and negative (90%). Moreover, the dot-ELISA could detect the HCV target
antigen in sera negative for anti-HCV Abs, but positive for HCV-
RNA, and in sera of HCV infected individuals with low
viremia, as well as those with high
viremia, using quantitative RT-PCR. Accordingly, the developed highly sensitive and specific HCV
antigen detection method could be applied for mass screening of HCV
infection.